These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11389794)

  • 21. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
    Ashford S; Turner-Stokes L
    Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
    Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
    Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spasticity must be treated by botulinum toxin with rehabilitaiton].
    Masakado Y
    Rinsho Shinkeigaku; 2013; 23(11):1261-3. PubMed ID: 24291950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.
    Lee JM; Gracies JM; Park SB; Lee KH; Lee JY; Shin JH
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30366407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment for flexed-elbow deformity during gait following botulinum toxin A treatment.
    Tanikawa H; Kagaya H; Inagaki K; Kotsuji Y; Suzuki K; Fujimura K; Mukaino M; Hirano S; Saitoh E; Kanada Y
    Gait Posture; 2018 May; 62():409-414. PubMed ID: 29649706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain and Muscles Properties Modifications After Botulinum Toxin Type A (BTX-A) and Radial Extracorporeal Shock Wave (rESWT) Combined Treatment.
    Megna M; Marvulli R; Farì G; Gallo G; Dicuonzo F; Fiore P; Ianieri G
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1127-1133. PubMed ID: 30843498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury.
    Smith SJ; Ellis E; White S; Moore AP
    Clin Rehabil; 2000 Feb; 14(1):5-13. PubMed ID: 10688339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A; Cinone N; Panza F; Letizia S; Santoro L; Lozupone M; Daniele A; Picelli A; Baricich A; Intiso D; Ranieri M
    Drugs; 2019 Feb; 79(2):143-160. PubMed ID: 30623347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.